Meanwhile, lncRNA-H19 is enriched in CD90+ liver cancer cells, and antisense H19 oligonucleotide transfection induces a remarkable increase in the ratio of MDR1 promoter methylation, which gives rise to doxorubicin accumulation [35, 36]. Here, THY1 is linked to liver cancer.